NCT02030834 · Interventional trial
Phase IIa Study of Redirected Autologous T Cells Engineered to Contain Anti-CD19 Attached to TCRz and 4-Signaling Domains in Patients With Chemotherapy Relapsed or Refractory CD19+ Lymphomas
Overall registry status Completed
Phase 2
Conditions Non-Hodgkins Lymphoma (NHL) Patients, With CD19+B Cell Lymphomas
Delaware Valley sites
- Abramson Cancer Center of the University of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory